News & Updates

Show Multimedia Only
Diabetes and COVID-19: What have we learned so far?

Diabetes and COVID-19: What have we learned so far?

09 Dec 2022 byKanas Chan

Evidence for excess risk and increased burden of new-onset diabetes among COVID-19 survivors is robust, and most antihyperglycaemic drugs can be used safely during acute COVID-19, with some drugs potentially offering protection against serious complications, according to data presented at 5th EDM HK.

Diabetes and COVID-19: What have we learned so far?

09 Dec 2022
Bacteraemia, UTI not uncommon in paediatric renal transplant recipients

Bacteraemia, UTI not uncommon in paediatric renal transplant recipients

08 Dec 2022
Progestin shows therapeutic potential in PR-positive endometrial cancer

Progestin shows therapeutic potential in PR-positive endometrial cancer

08 Dec 2022